Nyresygdom ved type 2-diabetes

1 Citationer (Scopus)

Abstract

Diabetic nephropathy is the leading cause of end stage renal disease in the Western world. 30-35% of the patients with type 2 diabetes will have micro- or macroalbuminuria, warranting yearly screening. Treatment to prevent diabetic nephropathy is multifactorial, adressing known progression promoters such as blood pressure, glycaemia, dyslipidaemia and smoking and includes antithrombotic prophylaxis. Although progress has been made over the last few decades, there is still an unmet need for improved screening, prevention and treatment since both cardiac and renal morbidity and mortality remains severe in this group of patients.

Bidragets oversatte titelRenal disease by type 2 diabetes
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind174
Udgave nummer37
Sider (fra-til)2150-4
Antal sider5
ISSN0041-5782
StatusUdgivet - 10 sep. 2012
Udgivet eksterntJa

Emneord

  • Albuminuria
  • Diabetes Mellitus, Type 2
  • Diabetic Nephropathies
  • Glomerular Filtration Rate
  • Humans
  • Kidney Failure, Chronic
  • Mass Screening
  • Reference Values

Fingeraftryk

Dyk ned i forskningsemnerne om 'Nyresygdom ved type 2-diabetes'. Sammen danner de et unikt fingeraftryk.

Citationsformater